Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease that develops when your blood cells are formed. It can lead to the abnormal destruction of blood cells, resulting in various symptoms.

17,18,19 Fabhalta is indicated as monotherapy in the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have hemolytic anemia. Fabhalta is only available through a ...

Researchers determined patients with paroxysmal hemoglobinuria may benefit from receiving ravulizumab over the long term.

With biosimilars to AstraZeneca’s blockbuster rare blood disease med Soliris recently available in the U.S., nonprofit health ...

KORU Medical Systems, Inc.’s KRMD share price has surged by 5.80%, which has investors questioning if this is right time to ...

“Individuals living with rare diseases, including paroxysmal nocturnal hemoglobinuria ... “Life-threatening diseases such as PNH, aHUS and gMG, if left untreated, can lead to kidney disease ...

EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized ...

for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine ...

“Individuals living with rare diseases, including paroxysmal nocturnal hemoglobinuria ... “Life-threatening diseases such as PNH, aHUS and gMG, if left untreated, can lead to kidney disease ...